34. Neurofibromatosis Clinical trials / Disease details


Clinical trials : 137 Drugs : 213 - (DrugBank : 76) / Drug target genes : 87 - Drug target pathways : 200

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT02718131
(ClinicalTrials.gov)
March 20167/3/2016A Study of INFUSE Bone Graft (BMP-2) in the Treatment of Tibial Pseudarthrosis in Neurofibromatosis Type 1 (NF1)A Study of INFUSE Bone Graft (Recombinant Human Bone Morphogenetic Protein-2/Absorbable Collagen Sponge) in the Treatment of Tibial Pseudarthrosis in Neurofibromatosis 1 (NF1)NF1;Congenital Pseudarthrosis of TibiaDevice: INFUSE Bone Graft (BMP-2);Procedure: Control GroupUniversity of Alabama at BirminghamThe Children's Tumor Foundation;MedtronicActive, not recruiting2 Years18 YearsAll54N/AUnited States;Australia